3rd Quarter - Report

THORN RUN PARTNERS for NOVARTIS CORPORATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to the Orphan Drug Tax and Tax Extenders; S.2260, EXPIRE Act of 2014.

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
WILLIAM CHRISTOPHER LAMOND —
ANDREW ROSENBERG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2260 (113th)

Medical/Disease Research/Clinical Labs MED

Issues related to biologics.

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
WILLIAM CHRISTOPHER LAMOND —
ANDREW ROSENBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Implementation issues related to the Patient Protection and Affordable Care Act (P.L. 111-148).

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
WILLIAM CHRISTOPHER LAMOND —
ANDREW ROSENBERG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Implementation issues related to the Patient Protection and Affordable Care Act (P.L. 111-148).

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
WILLIAM CHRISTOPHER LAMOND —
ANDREW ROSENBERG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.